Immunoregulation by antibody secreting cells in inflammation, infection, and cancer.
Shannon Eileen McGettiganGudrun F DebesPublished in: Immunological reviews (2021)
Antibody-secreting cells (ASCs) are considered work horses of the humoral immune response for their tireless effort to produce large amounts of antibodies that fulfill an array of functions in host defense, inflammation, and maintenance of homeostasis. While traditionally considered largely senescent cells, surprising recent findings demonstrate that subsets of ASCs downmodulate ongoing immune responses independent of antibody formation. Such regulatory ASCs produce IL-10 or IL-35 and are implicated in maintaining tissue and immune homeostasis. They also serve to suppress pathogenic leukocytes in infection, allergy, and inflammatory diseases that affect tissues, such as the central nervous system and the respiratory tract. Additionally, regulatory ASCs infiltrate various cancer types and restrict effective anti-tumor T cell responses. While incompletely understood, there is significant overlap in factors that control ASC differentiation, IL-10 expression by B cells and the generation of ASCs that secrete both antibodies and IL-10. In this review, we will cover the biology, phenotype, generation, maintenance and function of regulatory ASCs in various tissues under pathological and steady states. An improved understanding of the development of regulatory ASCs and their biological roles will be critical for generating novel ASC-targeted therapies for the treatment of inflammatory diseases, infection, and cancer.
Keyphrases
- immune response
- induced apoptosis
- oxidative stress
- papillary thyroid
- transcription factor
- cell cycle arrest
- squamous cell
- respiratory tract
- endoplasmic reticulum stress
- peripheral blood
- dendritic cells
- poor prognosis
- mass spectrometry
- nlrp inflammasome
- high resolution
- toll like receptor
- childhood cancer
- combination therapy